Viewing Study NCT01106534

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-26 @ 7:08 PM
Study NCT ID: NCT01106534
Status: COMPLETED
Last Update Posted: 2023-11-14
First Post: 2010-04-16
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort
Sponsor: Abbott Medical Devices
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Total Occlusion of Coronary Artery View
None Vascular Disease View
None Myocardial Ischemia View
None Coronary Artery Stenosis View
None Coronary Disease View
None Coronary Artery Disease View
None Coronary Restenosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None drug eluting stents View
None Stents View
None Angioplasty View
None Stent thrombosis View
None antiplatelet treatment View